Shopping Cart
Your Cart is Empty
There was an error with PayPalClick here to try again
CelebrateThank you for your business!You should be receiving an order confirmation from Paypal shortly.Exit Shopping Cart


October 22, 2022

Correspondence sent to Senator's Chuck Grassley, Senator Ron Johnson, Senator Roger Marshall MD and, Senator Marsha Blackburn sharing our concerns regarding the clinical intramural and extramural clinical trials being funded at National Institutes of Health (NIH), Agency Healthcare Research & Quality (AHRQ), the Veterans Association (VA) and the Patient-Centered Outcomes Research Institute (PCORI).

July 16, 2021

CIAAG remitted formal comments to the CDC Board of Scientific Counselors for the National Center for Injury Prevention and Control regarding their initial  "Observations of the Opioid Workgroup" for the 2016 CDC Guideline for Prescribing Opioids. 

May 6, 2021

CIAAG submitted an Appropriations Request to the House Subcommittee on Labor, Health & Human Services, and Education asking for monies to be allocated for the creation of an Oversight Committee and to fund impact studies to determine the social and health implications on the recent healthcare changes on the public health and well-being.

December 10, 2020

CIAAG sends a copy of "Addressing the Tri-Crisis" to the Biden/Harris Administration. In this document, we outline goals and recommendations that we would like to see the administration take within the first 100 days of office.

May 14, 2020

CIAAG sent a joint letter to CMS requesting communication with the states to permit the dispensing of a 90 day supply of schedule II medications for patients during the COVID-19 pandemic.

November 11, 2019

CIAAG Members joined in our "Call to Action" to email lawmakers in all 50 states sharing our concerns regarding unqualified individuals, with personal bias and agendas, to be advising our lawmakers on healthcare policy and public health changes. Our members sent emails to every single lawmaker in their home state along with a copy of a recent publication, "Damaging State Legislation Regarding Opioids: The Need To Scrutinize Sources Of Inaccurate Information Provided To Lawmakers" which outlines this very issue.